Cancer metabolic networks: Metabolic pathways modeling and metabolomics in cancer research

Cancer Systems Biology

Volumn , Issue , 2010, Pages 143-164

  Cuperlovic Culf, Miroslava ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881195633     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781439811863     Document Type: Chapter

References (95)

1. Akiyama, K., Chikayama, E., Yuasa, H. et al. 2008. PRIMe: a Web site that assembles tools for metabolomics and transcriptomics. In Silico Biol. 8: 339-345.
2. Alon, U. 2007. An Introduction to Systems Biology. Chapman & Hill/CRC, Boca Raton, FL.
3. Barabasi, A. L. and Oltvai, Z. N. 2004. Network biology: understanding the cell’s functional organization. Nature. Rev. Genet. 5: 101-113.
4. Bensaad, K. and Vousden, K. H. 2007. p53: new roles in metabolism. Trends Cell Biol. 17: 286-291.
5. 2 availability on human cancer. Nature Rev. Cancer 8: 967-975.
6. Boros, L. G., Cascante, M., and Lee, W. N. 2002. Metabolic profiling of cell growth and death in cancer: applications in drug discovery. Drug Discov. Today 7: 364-372.
7. Boros, László G., Serkova, Natalie J., Cascante, Marta S., and Lee, Wai Nang Paul. 2004. Use of metabolic pathway flux information in targeted cancer drug design. Drug Discovery Today: Therapeutic Strategies 1: 435-443.
8. Brugarolas, J. and Kaelin, W. G., Jr. 2004. Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes. Cancer Cell 6: 7-10.
9. Chikayama, E., Suto, M., Nishihara, T. et al. 2008. Systematic NMR analysis of stable isotope labeled metabolite mixtures in plant and animal systems: coarse grained views of metabolic pathways. PLoS. One. 3: e3805.
10. Chmurny, G. N., Hilton, B. D., and Halverson, D. et al. 1988. An NMR blood test for cancer: a critical assessment. NMR Biomed 1: 136-150.
11. Costello, L. C. and Franklin, R. B. 2005. “Why do tumour cells glycolyse?": from glycolysis through citrate to lipogenesis. Mol. Cell Biochem. 280: 1-8.
12. Cui, Q., Lewis, I. A., Hegeman, A. D. et al. 2008. Metabolite identification via the Madison Metabolomics Consortium Database. Nature Biotechnol. 26: 162-164.
13. Cuperlovic-Culf, Miroslava, Belacel, Nabil, and Culf, A. S. 2008. Integrated analysis of transcriptomics and metabolomics profiles. Expert Opin. Med. Diagnostics 497-509.
14. Dang, C. V., Kim, J., Gao, P., and Yustein, J. 2008. The interplay between MYC and HIF in cancer. Nature Rev. Cancer 8: 51-56.
15. Dang, C. V., Lewis, B. C., Dolde, C., Dang, G., and Shim, H. 1997. Oncogenes in tumor metabolism, tumorigenesis, and apoptosis. J. Bioenerg. Biomembr. 29: 345-354.
16. Dang, C. V. and Semenza, G. L. 1999. Oncogenic alterations of metabolism. Trends Biochem. Sci. 24: 68-72.
17. DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., and Thompson, C. B. 2008a. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7: 11-20.
18. DeBerardinis, R. J., Sayed, N., Ditsworth, D., and Thompson, C. B. 2008b. Brick by brick: metabolism and tumor cell growth. Curr. Opin. Genet. Dev. 18: 54-61.
19. DeGraaf, R. A. 2007. In Vivo NMR Spectroscopy. Wiley, Chichester, England.
20. Demin, O. and Goryanin, I. 2009. Kinetic Modelling in Systems Biology. Chapman & Hill/CRC, Boca Raton, FL.
21. Denkert, C., Budczies, J., Kind, T. et al. 2006. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res. 66: 10795-10804.
22. Denkert, C., Budczies, J., Weichert, W. et al. 2008. Metabolite profiling of human colon carcinoma: deregulation of TCA cycle and amino acid turnover. Mol. Cancer 7: 72.
23. Duarte, N. C., Becker, S. A., Jamshidi, N. et al. 2007. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. USA 104: 1777-1782.
24. Fernie, A. R., Trethewey, R. N., Krotzky, A. J., and Willmitzer, L. 2004. Metabolite profiling: from diagnostics to systems biology. Nature Rev. Mol. Cell Biol. 5: 763-769.
25. Fossel, E. T., Carr, J. M., and McDonagh, J. 1986. Detection of malignant tumors: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. N. Engl. J. Med. 315: 1369-1376.
26. Gillies, R. J. and Gatenby, R. A. 2007a. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? J. Bioenerg. Biomembr. 39: 251-257.
27. Gillies, R. J. and Gatenby, R. A. 2007b. Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev. 26: 311-317.
28. Goodacre, R. 2004. Metabolic profiling: pathways in discovery. Drug Discov. Today 9: 260-261.
29. Gordan, J. D., Thompson, C. B., and Simon, M. C. 2007. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 12: 108-113.
30. Gowda, G. A., Zhang, S., Gu, H. et al. 2008. Metabolomics-based methods for early disease diagnostics. Expert Rev. Mol. Diagn. 8: 617-633.
31. Griffin, J. L. and Shockcor, J. P. 2004. Metabolic profiles of cancer cells. Nature Rev. Cancer 4: 551-561.
32. Griffiths, J. R. and Stubbs, M. 2005. Cancer metabolic phenotype in the Oncegenesis Handbook, LaRochelle W. J., Shunketes, R. A. (eds), Humana Press, Totowa, New Jersey.
33. Hanahan, D. and Weinberg, R. A. 2000. The hallmarks of cancer. Cell 100: 57-70.
34. Herring, F. G., Phillips, P. S., Pritchard, H., Silver, H., and Whittal, K. P. 1990. The proton NMR of blood plasma and the test for cancer. Magn Reson. Med. 16: 35-48.
35. Holmes, E., Wilson, I. D., and Nicholson, J. K. 2008. Metabolic phenotyping in health and disease. Cell 134: 714-717.
36. Hsu, P. P. and Sabatini, D. M. 2008. Cancer cell metabolism: Warburg and beyond. Cell 134: 703-707.
37. Hucka, M., Finney, A., Sauro, H. M. et al. 2003. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 19: 524-531.
38. Jamshidi, N. and Palsson, B. O. 2008. Formulating genome-scale kinetic models in the post-genome era. Mol. Syst. Biol. 4: 171.
39. Kaelin, W. G., Jr. and Ratcliffe, P. J. 2008. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30: 393-402.
40. Karlebach, G. and Shamir, R. 2008. Modelling and analysis of gene regulatory networks. Nature Rev. Mol. Cell Biol. 9: 770-780.
41. Katajamaa, M. and Oresic, M. 2007. Data processing for mass spectrometry-based metabolomics. J. Chromatogr. A. 1158: 318-328.
42. Kell, D. B. 2004. Metabolomics and systems biology: making sense of the soup. Curr. Opin. Microbiol. 7: 296-307.
43. Kell, D. B. 2006. Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discov. Today 11: 1085-1092.
44. Kell, D. B. and Knowles, J. D. 2006. The role of modeling in systems biology. In Systems Modelling in Cellular Biology from Concepts to Nuts and Bolts. Szallasi, Z. et al. (eds.), MIT Press, pp. 3-18.
45. Kim, Y. and Maruvada, P. 2008. Frontiers in metabolomics for cancer research: Proceedings of a National Cancer Institute workshop. Metabolomics 4: 105-113.
46. Kondoh, H., Lleonart, M. E., Gil, J. et al. 2005. Glycolytic enzymes can modulate cellular life span. Cancer Res. 65: 177-185.
47. Kuhajda, F. P. 2006. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 66: 5977-5980.
48. Lane, A. N., Fan, T. W., and Higashi, R. M. 2008. Stable isotope-assisted metabolomics in cancer research. IUBMB Life 60: 124-129.
49. Lenz, E. M. and Wilson, I. D. 2007. Analytical strategies in metabonomics. J. Proteome. Res. 6: 443-458.
50. Lewis, I. A., Schommer, S. C., Hodis, B. et al. 2007. Method for determining molar concentrations of metabolites in complex solutions from two-dimensional 1H-13C NMR spectra. Anal. Chem. 79: 9385-9390.
51. Lindon, J. C., Nicholson, J. K., and Holmes, E. (Editors) 2007. The Handbook of Metabonomics and Metabolomics. Elsevier Science, New York.
52. Little, J. L. and Kridel, S. J. 2008. Fatty acid synthase activity in tumor cells. Subcell. Biochem. 49: 169-194.
53. Lutz, N. W. 2005. From metabolic to metabolomic NMR spectroscopy of apoptotic cells. Metabolomics 1: 251-268.
54. Ma, H., Sorokin, A., Mazein, A. et al. 2007a. The Edinburgh human metabolic network reconstruction and its functional analysis. Mol. Syst. Biol. 3: 135.
55. Ma, W., Sung, H. J., Park, J. Y., Matoba, S., and Hwang, P. M. 2007b. A pivotal role for p53: balancing aerobic respiration and glycolysis. J. Bioenerg. Biomembr. 39: 243-246.
56. Mantovani, A. 2009. Cancer: inflaming metastasis. Nature 457: 36-37.
57. Matoba, S., Kang, J. G., Patino, W. D. et al. 2006. p53 regulates mitochondrial respiration. Science 312: 1650-1653.
58. Mavrovouniotis, M. L. 1991. Estimation of standard Gibbs energy changes of biotransformations. J. Biol. Chem. 266: 14440-14445.
59. Menendez, J. A. and Lupu, R. 2007. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nature Rev. Cancer 7: 763-777.
60. Michelakis, E. D., Webster, L., and Mackey, J. R. 2008. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br. J. Cancer 99: 989-994.
61. Nakayama, Y., Kinoshita, A., and Tomita, M. 2005. Dynamic simulation of red blood cell metabolism and its application to the analysis of a pathological condition. Theor. Biol. Med. Model. 2: 18.
62. Nordstrom, A., O’Maille, G., Qin, C., and Siuzdak, G. 2006. Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum. Anal. Chem. 78: 3289-3295.
63. Oliver, S. G. 2002. Functional genomics: lessons from yeast. Philos. Trans. R. Soc. Lond. B Biol. Sci. 357: 17-23.
64. Oliver, S. G., Winson, M. K., Kell, D. B., and Baganz, F. 1998. Systematic functional analysis of the yeast genome. Trends Biotechnol. 16: 373-378.
65. Orton, R. J., Sturm, O. E., Vyshemirsky, V. et al. 2005. Computational modelling of the receptortyrosine-kinase-activated MAPK pathway. Biochem. J. 392: 249-261.
66. Paley, S. M. and Karp, P. D. 2006. The Pathway Tools cellular overview diagram and Omics Viewer. Nucleic Acids Res. 34: 3771-3778.
67. Palsson, B. O. 2006. Systems Biology: Properties of Reconstructed Networks. Cambridge University Press, New York.
68. Raman, K. and Chandra, N. 2009. Flux balance analysis of biological systems: applications and challenges. Brief. Bioinform. 10: 435-449.
69. Ramanathan, A., Wang, C., and Schreiber, S. L. 2005. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc. Natl. Acad. Sci. USA 102: 5992-5997.
70. Rangamani, P. and Iyengar, R. 2008. Modelling cellular signalling systems. Essays Biochem. 45: 83-94.
71. Rashid, A., Pizer, E. S., Moga, M. et al. 1997. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am. J. Pathol. 150: 201-208.
72. Reed, J. L. and Palsson, B. O. 2003. Thirteen years of building constraint-based in silico models of Escherichia coli. J. Bacteriol. 185: 2692-2699.
73. Richardson, A. D., Yang, C., Osterman, A., and Smith, J. W. 2008. Central carbon metabolism in the progression of mammary carcinoma. Breast Cancer Res. Treat. 110: 297-307.
74. Rojas, I., Golebiewski, M., Kania, R., Kreb, O., Mir, S., Weidemann, A., Wittig, U. 2007. SABIO: a database for biochemical reactions and their kinetics. BMC Sys. Biol. (suppliment 1): 56.
75. Serkova, N. J. and Niemann, C. U. 2006. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics. Expert. Rev. Mol. Diagn. 6: 717-731.
76. Sonveaux, P., Vegran, F., Schroeder, T. et al. 2008. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J. Clin. Invest. 118: 3930-3942.
77. Sreekumar, A., Poisson, L. M., Rajendiran, T. M. et al. 2009. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910-914.
78. Steuer, R., Kurths, J., Fiehn, O., and Weckwerth, W. 2003. Observing and interpreting correlations in metabolomic networks. Bioinformatics 19: 1019-1026.
79. ter Kuile, B. H. and Westerhoff, H. V. 2001. Transcriptome meets metabolome: hierarchical and metabolic regulation of the glycolytic pathway. FEBS Lett. 500: 169-171.
80. Trygg, J., Holmes, E., and Lundstedt, T. 2007. Chemometrics in metabonomics. J. Proteome. Res. 6: 469-479.
81. Vallabhajosula, S. 2007. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Semin. Nucl. Med. 37: 400-419.
82. Villas-Boas, S. G., Mas, S., Akesson, M., Smedsgaard, J., and Nielsen, J. 2005. Mass spectrometry in metabolome analysis. Mass Spectrom. Rev. 24: 613-646.
83. Vizan, P., Mazurek, S., and Cascante. 2008. Robust metabolic adaptation underlying tumour progression. Metabolomics 4: 1-12.
84. Vogelstein, B., Lane, D., and Levine, A. J. 2000. Surfing the p53 network. Nature 408: 307-310.
85. Warburg, O. 1925. Uber den Stoffwechsel der Carcinomzelle. Klin. Wochenschr. Berl. 4: 534-536.
86. Warburg, O. 1956. On the origin of cancer cells. Science 123: 309-314.
87. Weljie, A. M., Newton, J., Mercier, P., Carlson, E., and Slupsky, C. M. 2006. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal. Chem. 78: 4430-4442.
88. Wishart, D. S. 2008. Quantitative metabolomics using NMR. Trends Anal. Chem. 27: 228-237.
89. Wishart, D. S., Tzur, D., Knox, C. et al. 2007. HMDB: the Human Metabolome Database. Nucleic Acids Res. 35: D521-D526.
90. Xia, J., Bjorndahl, T. C., Tang, P., and Wishart, D. S. 2008. MetaboMiner: semi-automated identification of metabolites from 2D NMR spectra of complex biofluids. BMC Bioinformatics 9: 507.
91. Yang, C., Richardson, A. D., Smith, J. W., and Osterman, A. 2007. Comparative metabolomics of breast cancer. Pac. Symp. Biocomput. 181-192.
92. Yeung, S. J., Pan, J., and Lee, M. H. 2008. Roles of p53, MYC and HIF-1 in regulating glycolysis: the seventh hallmark of cancer. Cell Mol. Life Sci. 65: 3981-3999.
93. Young, C. D. and Anderson, S. M. 2008. Sugar and fat-that’s where it’s at: metabolic changes in tumors. Breast Cancer Res. 10: 202.
94. Zamboni, N. and Kümmel. 2008. anNET: a tool for network-embedded thermodynamic analysis of quantitative metabolome data 9: 199.
95. Zhang, F., Bruschweiler-Li, L., Robinette, S. L., and Bruschweiler, R. 2008. Self-consistent metabolic mixture analysis by heteronuclear NMR: application to a human cancer cell line. Anal. Chem. 80: 7549-7553.